Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [NA]

View source ↗

Summary

A completed clinical trial evaluating a vaccine therapy plus sargramostim in patients with stage IV malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | NA | Status: COMPLETED